1. Artificial Neural Network Model for Liver Cirrhosis Diagnosis in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
- Author
-
Yan Lin, Guo-bin Wu, Rong Liang, Su-su Wu, Yi-shuai Mo, Xuemin Piao, Jie Zeng, Rongyun Mai, Jiazhou Ye, Xing Gao, and Le-Qun Li
- Subjects
medicine.medical_specialty ,Multivariate analysis ,Cirrhosis ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Logistic regression ,medicine.disease_cause ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Pharmacology (medical) ,In patient ,030212 general & internal medicine ,General Pharmacology, Toxicology and Pharmaceutics ,Prothrombin time ,Hepatitis B virus ,Chemical Health and Safety ,medicine.diagnostic_test ,business.industry ,General Medicine ,medicine.disease ,Hepatocellular carcinoma ,Hepatectomy ,business ,Safety Research - Abstract
Background Testing for the presence of liver cirrhosis (LC) is one of the most critical diagnostic and prognostic assessments for patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). More non-invasive tools are needed to diagnose LC but the predictive abilities of current models are still inconclusive. This study aimed to develop and validate a novel and non-invasive artificial neural network (ANN) model for diagnosing LC in patients with HBV-related HCC using routine laboratory serological indicators. Methods A total of 1152 HBV-related HCC patients who underwent hepatectomy were included and randomly divided into the training set (n = 864, 75%) and validation set (n = 288, 25%). The ANN model was constructed from the training set using multivariate Logistic regression analysis and then verified in the validation set. Results The morbidity of LC in the training and validation sets was 41.2% and 46.8%, respectively. Multivariate analysis showed that age, platelet count, prothrombin time and total bilirubin were independent risk factors for LC (P < 0.05). The area under the ROC curve (AUC) analyses revealed that the ANN model had higher predictive accuracy than the Logistic model (ANN: 0.757 vs Logistic: 0.721; P < 0.001), and other scoring systems (ANN: 0.757 vs CP: 0.532, MELD: 0.594, ALBI: 0.575, APRI: 0.621, FIB-4: 0.644, AAR: 0.491, and GPR: 0.604; P < 0.05 for all) in diagnosing LC. Similar results were obtained in the validation set. Conclusion The ANN model has better diagnostic capabilities than other commonly used models and scoring systems in assessing LC risk in patients with HBV-related HCC.
- Published
- 2020